Hinge Health Inc. (NYSE:HNGE - Get Free Report) major shareholder Insight Holdings Group, Llc sold 530,982 shares of the business's stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $71.82, for a total value of $38,135,127.24. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Insight Holdings Group, Llc also recently made the following trade(s):
- On Monday, June 29th, Insight Holdings Group, Llc sold 1,466,667 shares of Hinge Health stock. The shares were sold at an average price of $82.83, for a total transaction of $121,484,027.61.
- On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The shares were sold at an average price of $71.67, for a total transaction of $10,199,429.37.
- On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The stock was sold at an average price of $71.15, for a total transaction of $27,813,744.55.
- On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The shares were sold at an average price of $70.21, for a total transaction of $7,897,010.17.
- On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The shares were sold at an average price of $70.95, for a total transaction of $15,921,109.05.
- On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total transaction of $4,614,279.16.
Hinge Health Stock Performance
Shares of NYSE:HNGE opened at $83.37 on Wednesday. The company has a fifty day moving average of $58.49 and a 200-day moving average of $48.00. The company has a market capitalization of $6.45 billion and a PE ratio of -6.76. Hinge Health Inc. has a 52-week low of $30.08 and a 52-week high of $84.62.
Hinge Health (NYSE:HNGE - Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.33. The company had revenue of $182.31 million for the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The company's revenue was up 47.2% compared to the same quarter last year. During the same period last year, the business earned $1.30 EPS. On average, equities analysts forecast that Hinge Health Inc. will post 1.33 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on HNGE shares. KeyCorp boosted their price target on Hinge Health from $75.00 to $90.00 and gave the stock an "overweight" rating in a report on Friday, June 12th. Weiss Ratings upgraded shares of Hinge Health from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, May 6th. Canaccord Genuity Group boosted their target price on shares of Hinge Health from $65.00 to $76.00 and gave the stock a "buy" rating in a report on Monday, June 15th. Citigroup restated an "outperform" rating on shares of Hinge Health in a research report on Wednesday, May 6th. Finally, Barclays raised their price target on shares of Hinge Health from $62.00 to $70.00 and gave the company an "overweight" rating in a research note on Thursday, June 11th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Hinge Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.80.
Get Our Latest Research Report on HNGE
Institutional Investors Weigh In On Hinge Health
Institutional investors and hedge funds have recently made changes to their positions in the business. BIT Capital GmbH grew its stake in Hinge Health by 79.3% during the fourth quarter. BIT Capital GmbH now owns 3,316,101 shares of the company's stock worth $154,033,000 after purchasing an additional 1,466,577 shares during the period. Vanguard Group Inc. lifted its stake in Hinge Health by 110.5% in the fourth quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company's stock valued at $121,027,000 after buying an additional 1,367,693 shares during the period. Tiger Global Management LLC boosted its holdings in shares of Hinge Health by 227.1% during the 4th quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company's stock worth $83,877,000 after buying an additional 1,253,743 shares in the last quarter. Millennium Management LLC grew its position in shares of Hinge Health by 225.0% during the 4th quarter. Millennium Management LLC now owns 1,479,642 shares of the company's stock worth $68,729,000 after buying an additional 1,024,317 shares during the period. Finally, Braidwell LP grew its position in shares of Hinge Health by 43.3% during the 4th quarter. Braidwell LP now owns 1,304,623 shares of the company's stock worth $60,600,000 after buying an additional 394,147 shares during the period.
Hinge Health Company Profile
(
Get Free Report)
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
